Clinical TopicsMusculoskeletal/OrthopedicsTechnologyWeb Exclusives

FDA seeks advice on metal-on-metal hip replacements

Share

On March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement systems will take place June 27-28. The FDA wants to know more about the risk and benefits of the systems, their use, and the management of patients. Read more.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

Which of the following patients is at the highest risk for developing autonomic dysreflexia (AD)?

Recent Posts